X-130384742-G-C
Position:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_178471.3(GPR119):āc.706C>Gā(p.Leu236Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00316 in 1,210,292 control chromosomes in the GnomAD database, including 7 homozygotes. There are 1,303 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ).
Frequency
Genomes: š 0.0023 ( 1 hom., 73 hem., cov: 23)
Exomes š: 0.0032 ( 6 hom. 1230 hem. )
Consequence
GPR119
NM_178471.3 missense
NM_178471.3 missense
Scores
3
14
Clinical Significance
Conservation
PhyloP100: 1.35
Genes affected
GPR119 (HGNC:19060): (G protein-coupled receptor 119) This gene encodes a member of the rhodopsin subfamily of G-protein-coupled receptors that is expressed in the pancreas and gastrointestinal tract. The encoded protein is activated by lipid amides including lysophosphatidylcholine and oleoylethanolamide and may be involved in glucose homeostasis. This protein is a potential drug target in the treatment of type 2 diabetes.[provided by RefSeq, Jan 2010]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.012250364).
BP6
Variant X-130384742-G-C is Benign according to our data. Variant chrX-130384742-G-C is described in ClinVar as [Likely_benign]. Clinvar id is 778985.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-130384742-G-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population mid. gnomad4_exome allele frequency = 0.00324 (3563/1098114) while in subpopulation MID AF= 0.0196 (81/4134). AF 95% confidence interval is 0.0162. There are 6 homozygotes in gnomad4_exome. There are 1230 alleles in male gnomad4_exome subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Hemizygotes in GnomAd4 at 73 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
GPR119 | NM_178471.3 | c.706C>G | p.Leu236Val | missense_variant | 1/2 | ENST00000682440.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
GPR119 | ENST00000682440.1 | c.706C>G | p.Leu236Val | missense_variant | 1/2 | NM_178471.3 | P1 | ||
GPR119 | ENST00000276218.4 | c.706C>G | p.Leu236Val | missense_variant | 1/1 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00229 AC: 257AN: 112124Hom.: 1 Cov.: 23 AF XY: 0.00213 AC XY: 73AN XY: 34268
GnomAD3 genomes
AF:
AC:
257
AN:
112124
Hom.:
Cov.:
23
AF XY:
AC XY:
73
AN XY:
34268
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00219 AC: 402AN: 183268Hom.: 0 AF XY: 0.00245 AC XY: 166AN XY: 67760
GnomAD3 exomes
AF:
AC:
402
AN:
183268
Hom.:
AF XY:
AC XY:
166
AN XY:
67760
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00324 AC: 3563AN: 1098114Hom.: 6 Cov.: 32 AF XY: 0.00338 AC XY: 1230AN XY: 363468
GnomAD4 exome
AF:
AC:
3563
AN:
1098114
Hom.:
Cov.:
32
AF XY:
AC XY:
1230
AN XY:
363468
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00228 AC: 256AN: 112178Hom.: 1 Cov.: 23 AF XY: 0.00213 AC XY: 73AN XY: 34332
GnomAD4 genome
AF:
AC:
256
AN:
112178
Hom.:
Cov.:
23
AF XY:
AC XY:
73
AN XY:
34332
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
10
ALSPAC
AF:
AC:
6
ESP6500AA
AF:
AC:
1
ESP6500EA
AF:
AC:
26
ExAC
AF:
AC:
297
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 20, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T
FATHMM_MKL
Benign
D
LIST_S2
Benign
T
M_CAP
Uncertain
D
MetaRNN
Benign
T
MetaSVM
Benign
T
MutationAssessor
Benign
L
MutationTaster
Benign
D
PrimateAI
Uncertain
T
PROVEAN
Benign
N
REVEL
Benign
Sift
Benign
T
Sift4G
Benign
T
Polyphen
P
Vest4
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at